News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tioga Pharmaceuticals Announces $24 Million Series A Financing


1/6/2006 11:12:08 AM

SAN DIEGO--(BUSINESS WIRE)--Jan. 6, 2006--Tioga Pharmaceuticals Incorporated announced today a $24 million Series A financing. Tioga Pharmaceuticals is engaged in the development of novel therapies for the treatment of gastrointestinal diseases. Tioga is developing asimadoline, a proprietary small molecule, for treating irritable bowel syndrome (IBS) and post operative ileus.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES